DIA is establishing a new platform to support health care innovation by connecting all stakeholders that today are key to the success of BioVentures, and to continued patient access to innovation.
The DIA BioVenture Day's unique value is in bringing together people from a much broader set of faculties via the neutral and trusted DIA platform, in order to gain a more holistic view on the role of bioventure companies and venture capital funding models.
Explore with us how best to address white spots of unmet medical need. We will review the efficiency and connectivity of bioventure approaches to existing development pipelines, health care product regulation, and value assessments in order to accelerate true innovation in health care.
WHAT WILL YOU GAIN?
Interact with all relevant stakeholders: bioventure companies, venture capitalists, regulators, policy makers, payers, patients, and big pharma
Develop solutions how to overcome hurdles to funding innovation and achieving reimbursement
Debate whether micro-innovation is clogging up the funding system
Assessment of evolving venture capital models, e.g. philanthropic approaches
On Tuesday March 28, 2017 at 10:00 am (ends 8:00 pm)
Category: Conferences - Science, Health & Medicine - Pharmaceuticals